Business
Herbalife : Reports First Quarter 2026 Net Sales Growth and Adjusted EBITDA¹ Above Guidance; Raises Full-Year 2026 Constant Currency² Net Sales and Adjusted EBITDA¹ Guidance Midpoints
Herbalife : Reports First Quarter 2026 Net Sales Growth and Adjusted EBITDA¹ Above Guidance; Raises Full-Year 2026 Constant Currency² Net Sales and Adjusted

About this update from Herbalife Ltd.
Herbalife Reports First Quarter 2026 Net Sales Growth and Adjusted EBITDA1 Above Guidance; Raises Full-Year 2026 Constant Currency2 Net Sales and Adjusted EBITDA1 Guidance Midpoints Q1 Results in Line with Preliminary Results Announced on April 14 LOS ANGELES, May 6, 2026 - Herbalife Ltd. (NYSE: HLF) today reported financial results for the first quarter ended March 31, 2026: Highlights "We delivered strong Q1 results that exceeded guidance and we successfully completed our debt refinancing. At the same time, we took further strategic actions to build on Herbalife's deep-rooted strength in personalization, enhance speed to market capabilities, and position us for long-term growth and value creation." - Stephan Gratziani, CEO First Quarter 2026 Net sales of $1.3 billion exceeds guidance o Up 7.8% vs. Q1 '25 Up 5.4% year-over-year on constant currency basis2; exceeds guidance Net income attributable to Herbalife of $61.9 million; adjusted net income1 of $69.0 million Adjusted EBITDA1 of $175.7 million exceeds guidance Adjusted EBITDA1 at constant currency2 of $180.3 million exceeds guidance Diluted EPS of $0.57; adjusted diluted EPS1 of $0.64 Net cash provided by operating activities of $113.8 million; capital expenditures of $10.9 million Reduced total leverage ratio to 2.7x and net leverage ratio1 to 2.1x at March 31 Recent Developments Completed $1.45 billion senior secured debt refinancing on April 29 Acquired substantially all of the assets of Bioniq's core personalized nutrition business on April 30 Outlook Second quarter 2026 guidance provided Full-year 2026 guidance revised: net sales and adjusted EBITDA1 ranges narrowed and constant currency2 midpoints increased, capital expenditures reaffirmed 1 Non-GAAP measure. Refer to Schedule A - "Reconciliation of Non-GAAP Financial Measures" for a detailed reconciliation of these measures to the most directly comparable U.S. GAAP measure for historical periods, as applicable, and a discussion of why the Company believes these non-GAAP measures are useful and certain information regarding non-GAAP guidance. 2 Non-GAAP measure. Refer to Schedule A - "Reconciliation of Non-GAAP Financial Measures" for a discussion of why the Company believes adjusting for the effects of foreign exchange is useful. Management Commentary Herbalife reported first quarter 2026 net sales of $1.3 billion, up 7.8% year-over-year, i...